ARAMARK investment thesis remains on track, says RW Baird Baird said the ARAMARK investment thesis remains on track following the company's beat and raise Q1 results. The firm cited improved margins and organic growth gains in both domestic and international markets. Shares are Outperform rated with a $32 price target.
News For ARMK From The Last 14 Days
Check below for free stories on ARMK the last two weeks.